Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1)

被引：0
|
作者：
Esteban Daudén
Pablo de la Cueva
Laura Salgado-Boquete
Mar Llamas-Velasco
Eduardo Fonseca
Ignasi Pau-Charles
David Asensio
Meritxell Guilà
José Manuel Carrascosa
机构：
[1] Hospital Universitario de la Princesa,Department of Dermatology, IIS
[2] Hospital Universitario Infanta Leonor,HP
[3] Complejo Hospitalario Universitario de Pontevedra,Department of Dermatology
[4] Complejo Hospitalario Universitario de A Coruña,Department of Dermatology
[5] Almirall S.A.,Department of Dermatology
[6] Hospital Universitari Germans Trias i Pujol,Department of Dermatology
来源：
Dermatology and Therapy | 2023年 / 13卷
关键词：
Clinical practice; Dimethyl fumarate; Efficacy; Psoriasis; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：329 / 345
页数：16
相关论文
共 50 条
  • [1] Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1)
    Dauden, Esteban
    de la Cueva, Pablo
    Salgado-Boquete, Laura
    Llamas-Velasco, Mar
    Fonseca, Eduardo
    Pau-Charles, Ignasi
    Asensio, David
    Guila, Meritxell
    Manuel Carrascosa, Jose
    [J]. DERMATOLOGY AND THERAPY, 2023, 13 (01) : 329 - 345
  • [2] Efficacy and safety of infliximab biosimilar in the treatment of moderate-to-severe plaque psoriasis: A 52-week clinical study
    Panagakis, Pantelis
    Rompoti, Natalia
    Stravodimou, Aristea
    Papoutsaki, Marina
    Rigopoulos, Dimitrios
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB198 - AB198
  • [3] Secukinumab treatment demonstrated high efficacy and safety in pediatric patients with moderate-to-severe plaque psoriasis: 52-week results from a randomized trial
    Magnolo, Nina
    Kingo, Kulli
    Laquer, Vivian
    Browning, John
    Reich, Adam
    Szepietowski, Jacek C.
    Keefe, Deborah
    Mazur, Rafal
    Ghelani, Prayashi
    Forrer, Pascal
    Patekar, Manmath
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB119 - AB119
  • [4] Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study
    Paller, Amy S.
    Flohr, Carsten
    Eichenfield, Lawrence F. F.
    Irvine, Alan D. D.
    Weisman, Jamie
    Soung, Jennifer
    Correia, Ana Pinto
    Natalie, Chitra R. R.
    Capriles, Claudia Rodriguez
    Pierce, Evangeline
    Reifeis, Sarah
    Lima, Renata Gontijo
    Tubau, Clara Armengol
    Laquer, Vivian
    Weidinger, Stephan
    [J]. DERMATOLOGY AND THERAPY, 2023, 13 (07) : 1517 - 1534
  • [5] Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study
    Amy S. Paller
    Carsten Flohr
    Lawrence F. Eichenfield
    Alan D. Irvine
    Jamie Weisman
    Jennifer Soung
    Ana Pinto Correia
    Chitra R. Natalie
    Claudia Rodriguez Capriles
    Evangeline Pierce
    Sarah Reifeis
    Renata Gontijo Lima
    Clara Armengol Tubau
    Vivian Laquer
    Stephan Weidinger
    [J]. Dermatology and Therapy, 2023, 13 (7) : 1517 - 1534
  • [6] Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Moderate to Severe Plaque Psoriasis: 52-Week Results
    Yoshinori Umezawa
    Akihiko Asahina
    Shinichi Imafuku
    Yayoi Tada
    Shigetoshi Sano
    Akimichi Morita
    Shinya Sakurai
    Naoki Hoshii
    Nicola Tilt
    Hidemi Nakagawa
    [J]. Dermatology and Therapy, 2021, 11 : 943 - 960
  • [7] Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Moderate to Severe Plaque Psoriasis: 52-Week Results
    Umezawa, Yoshinori
    Asahina, Akihiko
    Imafuku, Shinichi
    Tada, Yayoi
    Sano, Shigetoshi
    Morita, Akimichi
    Sakurai, Shinya
    Hoshii, Naoki
    Tilt, Nicola
    Nakagawa, Hidemi
    [J]. DERMATOLOGY AND THERAPY, 2021, 11 (03) : 943 - 960
  • [8] Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study
    Gnesotto, Laura
    Mioso, Guido
    Bardazzi, Federico
    Filippi, Federica
    Di Lernia, Vito
    Motolese, Alberto
    Di Nuzzo, Sergio
    Conti, Andrea
    Arginelli, Federica
    Corazza, Monica
    Odorici, Giulia
    Borghi, Alessandro
    Gisondi, Paolo
    Naldi, Luigi
    Dapavo, Paolo
    Parodi, Aurora
    Burlando, Martina
    Piaserico, Stefano
    [J]. ACTA DERMATO-VENEREOLOGICA, 2023, 103
  • [9] Long-term safety and efficacy of ropinirole in moderate-to-severe RLS: Results of two 52-week, open-label studies
    Dreykluft, T.
    Garcia-Borreguero, D.
    Lee, D.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 96 - 96
  • [10] Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study
    Pellacani, Giovanni
    Bigi, Laura
    Parodi, Aurora
    Burlando, Martina
    Lanna, Caterina
    Campione, Elena
    Rongioletti, Franco
    Mugheddu, Cristina
    Malara, Giovanna
    Moretti, Giovanna
    Stingeni, Luca
    Hansel, Katharina
    Micali, Giuseppe
    Naldi, Luigi
    Pirro, Federico
    Peris, Ketty
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
12345